BioSpace News Archive

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that Dr. Stuart Titus, the Company’s Chief Executive Officer, was featured in several national and international news publications

Amgen (NASDAQ: AMGN) today announced the first clinical results from a Phase 1 study evaluating investigational AMG 510, the first KRASG12C inhibitor to reach the clinical stage.

A promising and emerging Portugal based cannabis company, Funcrops opened its doors for investors.

Thermo Fisher Scientific announced that its Oncomine Dx Target Test CDx System has received reimbursement coverage from Japan’s Ministry of Health, Labour and Welfare and is now commercially available in that country.

Innovative solutions integrate new data acquisition, analytical and smart algorithm capabilities

Joint venture between Mobidiag and Autobio Diagnostics will commercialise Novodiag® platform and selected infectious disease assays in the Greater China territory

Partnership with U.S. Department of Energy and Agile BioFoundry to accelerate microbial engineering for cost-competitive production of new biochemicals

Vireo Health International, Inc., a leading science-focused, multi-state cannabis company, announced its participation at the following two upcoming conference events

Sobi, an international biopharmaceutical company transforming the lives of people affected by rare diseases, announced the launch of a new video that shows the role of interferon gamma in primary hemophagocytic lymphohistiocytosis and how Gamifant® may help.

US Department of State reached out to Dr. Oakley-Girvan, SVP of Research and Strategy, to invite Medable to attend as a fully sponsored entrepreneurial and innovative company